Natalia Burgos Polanco
Endocrinology, Diabetes & Metabolism · San Juan, PRNPI 1548688476
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $620 and has fallen 90.5% since, to $59 in 2023. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PR, where the typical reported total is $4,706.
Across 94 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$205
- Novo Nordisk$177
- Mannkind Corporation$159
- Amarin Pharma, Inc.$129
- Lilly USA, LLC$103
- Radius Health, Inc.$93
- plus $877 from 25 others
What the payments were for
- Food & beverage$1,742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 5 | $205 |
| Novo Nordisk | 13 | $177 |
| Mannkind Corporation | 9 | $159 |
| Amarin Pharma, Inc. | 8 | $129 |
| Lilly USA, LLC | 2 | $103 |
| Radius Health, Inc. | 5 | $93 |
| Abbott | 5 | $88 |
| AstraZeneca | 5 | $80 |
| Esperion Therapeutics, Inc. | 3 | $79 |
| Sanofi-aventis U.S. LLC | 4 | $78 |
| Amgen(2 entities) | 5 | $77 |
| Xeris Pharmaceuticals, Inc. | 3 | $50 |
| Amneal Pharmaceuticals LLC | 3 | $39 |
| Boehringer Ingelheim | 2 | $39 |
| AbbVie | 2 | $38 |
| Novartis | 2 | $33 |
| IBSA Pharma Inc. | 2 | $32 |
| Corcept Therapeutics | 2 | $29 |
| Pfizer | 1 | $25 |
| Clarus Therapeutics Inc. | 2 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Bayer | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Recordati_rare_diseases_inc. | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Merck | 1 | $11 |
| Dexcom, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,742 in reported general payments places this provider in the 25th percentile of 143 endocrinology, diabetes & metabolism providers in Puerto Rico.
See all endocrinology, diabetes & metabolism providers in Puerto Rico →
Other endocrinology, diabetes & metabolism in San Juan
- Manuel Alegre-HernandezSan Juan$156K
- Monica Ortiz-RiveraSan Juan$148K
- Alex Gonzalez BossoloSan Juan$110K
- Michelle Mangual GarciaSan Juan$87K
- Meliza Martinez RodriguezSan Juan$80K
- Jorge de Jesus MirandaSan Juan$30K
- Zahira Lugo LopezSan Juan$29K
- Oscar Ruiz BermudezSan Juan$27K
- Margarita Ramirez-VickSan Juan$15K
- Yanira Marrero McFalineSan Juan$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.